Is The iShares Emerging Markets Bond ETF (ASX:IHEB) Too Risky?
With interest rates continuing to fall, it’s increasingly difficult to generate a decent income through investing. Is the iShares J.P. Morgan USD Emerging Markets Bond ETF (ASX:IHEB) worth the risk?
3 Blue-Chip Dividend Shares For 2019 And Beyond
Here’s why I think shares of Cimic Group (ASX:CIM), Sydney Airport Holdings (ASX:SYD) and Transurban Group (ASX:TCL) are worth considering for a stable dividend portfolio.
Is The VanEck Floating Rate ETF (ASX:FLOT) A Good Income Bet For 2019?
In our low rate environment, it is increasingly difficult to find a reliable source of investment income. Could the VanEck Vectors Australian Floating Rate ETF (ASX:FLOT) be the solution?
Is The BetaShares Healthcare ETF (ASX:DRUG) A Healthy Option For Growth?
Healthcare companies have ageing population tailwinds and IP competitive advantages pushing their growth. The BetaShares Global Healthcare ETF (ASX: DRUG) wants to capitalise on that.
Is The AMP Global Infrastructure Fund (ASX:GLIN) A Good Option For Income And Growth?
The AMP Capital Global Infrastructure Securities Fund (ASX:GLIN) has many appealing traits, but it doesn’t come without risk. Could this active ETF work for your portfolio?
Why The iShares Consumer Staples ETF (IXI) Could Be A Staple In Your Portfolio
With fears of a recession rising, many investors are looking for a safe haven. Does the iShares Global Consumer Staples ETF (ASX:IXI) fit the bill?
Big 4 Banks On Sale – Is Now The Time To Buy?
The big 4 banks have been caught up in the market mayhem today, all dropping by more than 2%. Is now the time to buy National Australia Bank (ASX:NAB) and its peers?
What To Do (And Not Do) When The Sharemarket Is Down
Days like today can be difficult for investors who are watching months of capital gains disappear in a sea of red. So, here’s a tip. Stop looking at your portfolio.
Check out our ETF Strategy + portfolio for ‘no fuss’ investing!